Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA gives priority to Roche skin cancer drug vismodegib
FDA gives priority to Roche skin cancer drug vismodegib
FDA gives priority to Roche skin cancer drug vismodegib
Submitted by
admin
on November 9, 2011 - 12:07pm
Source:
Pharma Times, UK
News Tags:
Roche
vismodegib
FDA
skin cancer
basal cell carcinoma
hedgehog pathway inhibitor
Headline:
FDA gives priority to Roche skin cancer drug vismodegib
Do Not Allow Advertisers to Use My Personal information
